|
Rheumatoid Arthritis
Citations 21-30 of 36 total displayed.
|
Past content
(since Nov 1999):
|
- Reviews
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies: Systematic Review and Meta-analysis of Rare Harmful Effects in Randomized Controlled Trials
- Tim Bongartz; Alex J. Sutton; Michael J. Sweeting; Iain Buchan; Eric L. Matteson; Victor Montori
JAMA 2006; 295: 2275-2285.
[Abstract]
[Full text]
[PDF]
- Book and Media Reviews
Out of Joint: A Private and Public Story of Arthritis
- Katherine Gundling
JAMA 2006; 295: 1455-a-1456-a.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Early Rheumatoid Arthritis Treatments Weighed
- Mike Mitka
JAMA 2005; 294: 3073-3074.
[Extract]
[Full text]
[PDF]
- JAMA Patient Page
Juvenile Idiopathic Arthritis
- Sarah Ringold; Alison Burke; Richard M. Glass
JAMA 2005; 294: 1722.
[Extract]
[Full text]
[PDF]
[ Spanish PDF ]
- From the Centers for Disease Control and Prevention
Monitoring Progress in Arthritis ManagementUnited States and 25 States, 2003
-
JAMA 2005; 294: 789-790.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Rheumatoid Arthritis Trial
- Tracy Hampton
JAMA 2004; 292: 1419-b.
[Extract]
[Full text]
[PDF]
- From the Centers for Disease Control and Prevention
Prevalence of Doctor-Diagnosed Arthritis and Possible Arthritis30 States, 2002
-
JAMA 2004; 291: 2934-2935.
[Extract]
[Full text]
[PDF]
- From the Centers for Disease Control and Prevention
Update: Direct and Indirect Costs of Arthritis and Other Rheumatic ConditionsUnited States, 1997
-
JAMA 2004; 291: 2935-2936.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Use of Biologics for Rheumatoid Arthritis Tempered by Concerns Over Safety, Cost
- Sarah Pressman Lovinger
JAMA 2003; 289: 3229-3230.
[Extract]
[Full text]
[PDF]
- Contempo Updates
Progress in the Treatment of Rheumatoid Arthritis
- David S. Pisetsky; E. William St.Clair
JAMA 2001; 286: 2787-2790.
[Extract]
[Full text]
[PDF]
|
|